Skip to main content

Market Overview

IPO Outlook For The Week: Biotech, Real Estate, IT Solutions And Secondhand Luxury E-Tail

Share:
IPO Outlook For The Week: Biotech, Real Estate, IT Solutions And Secondhand Luxury E-Tail

For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. The IPO dates below are expected but not confirmed.

Cambium Networks Corp (CMBM) will issue 5.8 million shares between $13 and $15 Wednesday on the Nasdaq. The offering represents 22.7% of outstanding shares and is expected to raise $100.1 million. Headquartered in Illinois, Cambium markets software and hardware for business network connectivity.

Linx S.A. (LINX) will issue nearly 29.3 million shares at $8.68 Wednesday on the New York Stock Exchange. The offering represents 15.7% of outstanding shares and is expected to raise $292.2 million. The Brazilian tech company supports Latin American retailers with business management solutions software.

Adaptive Biotechnologies Corp (ADPT) will issue 12.5 million shares between $15 and $17 Thursday on the Nasdaq. The offering represents 10.6% of outstanding shares and is expected to raise $244.4 million. Based in Seattle, the biotech uses its proprietary immune profiling platform to target cancer, infectious diseases and autoimmune diseases.

Bridgebio Pharma, Inc. (BBIO) will issue 15 million shares between $14 and $16 Thursday on the Nasdaq. The offering represents 13% of outstanding shares and is expected to raise $276 million. The California biotech targets rare genetic diseases such as frequent basal cell carcinoma and achondroplasia.

Change Healthcare Inc. (CHNG) will issue nearly 42.9 million shares between $16 and $19 Thursday on the Nasdaq. The offering represents 36.2% of outstanding shares and is expected to raise $936.4 million. With operations in 120 global markets, Change provides technology and data solutions to streamline health care transactions.

Morphic Holding, Inc. (MORF) will issue 5 million shares between $14 and $16 Thursday on the Nasdaq. The offering represents 17.5% of outstanding shares and is expected to raise $92 million. The Massachusetts biotech develops therapies for autoimmune diseases, fibrotic diseases and cancer.

Priam Properties Inc. (PRMI) will issue 9 million shares between $18 and $20 Thursday on the New York Stock Exchange. The offering represents 99.9% of outstanding shares and is expected to raise $207 million. The Nashville-based real estate investment company acquires and manages multitenant office properties in midwest and southeast cities.

Karuna Therapeutics, Inc. (KRTX) will issue nearly 4.4 million shares between $15 and $17 Friday on the Nasdaq. The offering represents 20.5% of outstanding shares and is expected to raise $85.5 million. Based in Boston, the biopharmaceutical company develops treatments for schizophrenia, Alzheimer’s Disease and pain.

TheRealReal, Inc. (REAL) will issue 15 million shares between $17 and $19 Friday on the Nasdaq. The offering represents 18.1% of outstanding shares and is expected to raise $327.8 million. The online consignment market authenticates and sells secondhand luxury goods.

Related Links:

What Is Reg A+?

What Is A Lock-Up Expiration Date And Why Is It Important?

 

Related Articles (ADPT + BBIO)

View Comments and Join the Discussion!

Posted-In: Adaptive Biotechnologies Bridgebio Pharma Cambium Networks Change HealthcareNews Previews IPOs Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com